VKH
ATOS icon

Virtu KCG Holdings’s Atossa Therapeutics ATOS Stock Holding History

Virtu KCG Holdings’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$27K Buy
299
+21
+8% +$2.16K ﹤0.01% 2692
2017
Q1 		$38K Buy
278
+103
+59% +$26.3K ﹤0.01% 2885
2016
Q4 		$44K Buy
175
+104
+146% +$32.4K ﹤0.01% 3111
2016
Q3 		$27K Buy
71
+52
+274% +$31.2K ﹤0.01% 2891
2016
Q2 		$15K Sell
19
-9
-32% -$7.29K ﹤0.01% 2824
2016
Q1 		$26K Buy
28
+17
+155% +$15.7K ﹤0.01% 2563
2015
Q4 		$9K Buy
+11
New +$16.9K ﹤0.01% 3373
2015
Q3 		– Sell
-19
Closed -$59K – 3320
2015
Q2 		$59K Buy
19
+13
+217% +$51.9K ﹤0.01% 3032
2015
Q1 		$29K Sell
6
-13
-68% -$55.4K ﹤0.01% 2906
2014
Q4 		$71K Sell
19
-31
-62% -$87.4K ﹤0.01% 3335
2014
Q3 		$182K Buy
50
+33
+194% +$162K ﹤0.01% 2959
2014
Q2 		$78K Buy
17
+13
+325% +$50.6K ﹤0.01% 3344
2014
Q1 		$18K Sell
4
-4
-50% -$23.7K ﹤0.01% 3436
2013
Q4 		$49K Buy
+8
New +$52.7K ﹤0.01% 3602

Other funds holding ATOS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFW
Mosaic Family Wealth St. Louis, Missouri $384M AUM 21.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Virtu KCG Holdings's ATOS Position: Q2 2017 in Review

Virtu KCG Holdings increased its Atossa Therapeutics (ATOS) stake by 7.6% in Q2 2017, buying an estimated $2.16K and bringing the position to 299 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Virtu KCG Holdings first reported a position in ATOS in Q4 2013 and has held it in 14 quarters since. The position peaked at $182K in Q3 2014. 10 funds tracked by Wall St. Rank hold ATOS as of Q2 2017.

  • Virtu KCG Holdings held 299 shares of Atossa Therapeutics worth $27K as of Q2 2017.
  • Virtu KCG Holdings bought 21 Atossa Therapeutics shares in Q2 2017, an estimated $2.16K.
  • Atossa Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2692 holding.
  • Virtu KCG Holdings first reported a position in Atossa Therapeutics in Q4 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's Atossa Therapeutics position peaked at $182K in Q3 2014.
  • 10 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.